StockMacro
Menu

Tenet Healthcare Corporation New

$263.19 +49% in 6 monthsMarket cap $20.9B

THC on XNYS, Health Care, job postings

Measures activity, not value. Not investment advice.

Net income jumped 66% to $3.8B in 12 months while the stock rose 41% over the year.

  • GoodInstitutional holders up 16% to 776 in the latest quarter
  • BadInsiders sold $40.8M in 90 days and bought nothing

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Industry
Services-general medical & surgical hospitals, nec (Health Care)
Employees
99,000
Website
tenethealth.com
Listed
NYSE, US
Last results
29 Oct 2026
Next results
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $5.6B, net income $1.2B.
Quarter to 31 Dec 2021: revenue $5.0B, net income –Quarter to 31 Mar 2022: revenue $4.8B, net income $280.0MQuarter to 31 Mar 2022: revenue $4.8B, net income $280.0MQuarter to 30 Jun 2022: revenue $4.7B, net income $179.0MQuarter to 30 Jun 2022: revenue $4.7B, net income $179.0MQuarter to 30 Sep 2022: revenue $4.9B, net income $268.0MQuarter to 30 Sep 2022: revenue $4.9B, net income $268.0MQuarter to 31 Dec 2022: revenue $5.0B, net income $274.0MQuarter to 31 Dec 2022: revenue $5.0B, net income $274.0MQuarter to 31 Mar 2023: revenue $5.0B, net income $296.0MQuarter to 31 Mar 2023: revenue $5.0B, net income $296.0MQuarter to 30 Jun 2023: revenue $5.1B, net income $293.0MQuarter to 30 Jun 2023: revenue $5.1B, net income $293.0MQuarter to 30 Sep 2023: revenue $5.1B, net income $266.0MQuarter to 30 Sep 2023: revenue $5.1B, net income $266.0MQuarter to 31 Dec 2023: revenue $5.4B, net income $456.0MQuarter to 31 Dec 2023: revenue $5.4B, net income $456.0MQuarter to 31 Mar 2024: revenue $5.4B, net income $2.3BQuarter to 31 Mar 2024: revenue $5.4B, net income $2.3BQuarter to 30 Jun 2024: revenue $5.1B, net income $477.0MQuarter to 30 Jun 2024: revenue $5.1B, net income $477.0MQuarter to 30 Sep 2024: revenue $5.1B, net income $681.0MQuarter to 30 Sep 2024: revenue $5.1B, net income $681.0MQuarter to 31 Dec 2024: revenue $5.1B, net income $572.0MQuarter to 31 Dec 2024: revenue $5.1B, net income $572.0MQuarter to 31 Mar 2025: revenue $5.2B, net income $622.0MQuarter to 31 Mar 2025: revenue $5.2B, net income $622.0MQuarter to 30 Jun 2025: revenue $5.3B, net income $522.0MQuarter to 30 Jun 2025: revenue $5.3B, net income $522.0MQuarter to 30 Sep 2025: revenue $5.3B, net income $579.0MQuarter to 30 Sep 2025: revenue $5.3B, net income $579.0MQuarter to 31 Dec 2025: revenue $5.5B, net income $644.0MQuarter to 31 Dec 2025: revenue $5.5B, net income $644.0MQuarter to 31 Mar 2026: revenue $5.4B, net income $906.0MQuarter to 31 Mar 2026: revenue $5.4B, net income $906.0MQuarter to 30 Jun 2026: revenue $5.6B, net income $1.0BQuarter to 30 Jun 2026: revenue $5.6B, net income $1.0BQuarter to 30 Sep 2026: revenue $5.6B, net income $1.2BQuarter to 30 Sep 2026: revenue $5.6B, net income $1.2B
31 Dec 2021RevenueNet incometallest bar $5.6B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$5.6B$1.2B
30 Jun 2026$5.6B$1.0B
31 Mar 2026$5.4B$906.0M
31 Dec 2025$5.5B$644.0M
30 Sep 2025$5.3B$579.0M
30 Jun 2025$5.3B$522.0M
31 Mar 2025$5.2B$622.0M
31 Dec 2024$5.1B$572.0M
30 Sep 2024$5.1B$681.0M
30 Jun 2024$5.1B$477.0M
31 Mar 2024$5.4B$2.3B
31 Dec 2023$5.4B$456.0M
30 Sep 2023$5.1B$266.0M
30 Jun 2023$5.1B$293.0M
31 Mar 2023$5.0B$296.0M
31 Dec 2022$5.0B$274.0M
30 Sep 2022$4.9B$268.0M
30 Jun 2022$4.7B$179.0M
31 Mar 2022$4.8B$280.0M
31 Dec 2021$5.0B–
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $22.2B $20.9B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +6.2% +4.0%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $3.8B $2.3B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $34.47 $14.70
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 63.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 24.4% 16.7% -9.1%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 17.2% 11.0% 5.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 80.7% -44.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $3.3B $1.5B
CashCash, cash equivalents and short-term investments on the latest balance sheet. $2.7B $3.0B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $13.2B $13.2B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $10.6B $10.2B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 2.4 0.06
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $68.40
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 5.5 7.1
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.95 0.75
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.4 1.1
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 3.8 2.2

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Tenet Healthcare Corporation NewTHC (this company) $20.9B5.50.95+6.2%17.2%
Universal Health ServicesUHS $10.3B7.10.56+8.0%8.0%
HCA HealthcareHCA $99.3B14.71.3+5.8%8.6%
Surgery PartnersSGRY $3.5Bloss1.0+2.2%-2.6%
Ardent HealthARDT $2.1B14.50.33+2.0%2.3%
Guardant HealthGH $19.7Bloss15.4+42%-37.9%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$40.8M

bought $0, sold $40.8M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+16%

776 13F filers vs 667

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

92%

73.1M shares held by 13F filers (30 Sep 2026) of 79.6M outstanding (23 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.2%

1.8M shares sold short (30 Oct 2026) of 79.6M outstanding (23 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.2

1.8M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.3%

1.8M shares sold short in the report before, 1.8M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

50%

50% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 49%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

2,591

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+6.5%

$5.6B vs $5.3B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-29%

$198.0M vs $280.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$1.0M

the 12 months before: $57K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$4.8M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

21

21 articles in the last 7 days; its usual week has 6 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

3.5×

21 articles in the last 7 days; its usual week has 6.

Price $263.19 on 20 Nov 2026, +41% over 12 months (12-month range $161.37 to $292.97)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $63.2M in the last 12 months (the 12 months before: -$36.3M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 18 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $5.6B in the latest quarter, +6.5% on a year earlier.
Capital spending per quarter. Capital spending $198.0M in the latest quarter, -29% on a year earlier.
Institutional holders (13F filers). 776 13F filers reported holding it in the latest 13F quarter, +21% on a year earlier.
Federal obligations. Federal obligations: $970K published in the last 12 months, +618% on the 12 months before.
Lobbying spend. Lobbying spend: $4.8M published in the last 12 months, +38% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
10 Apr 20268-K and other filingsDirector or officer change
30 Mar 20268-K and other filingsDirector or officer change
30 Mar 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Jan 2026Sharp changeLobbying spend jump: lobbying spend jump, 1.2M vs usual 570K (2025-12-31); 2.1x the same period a year earlier
24 Nov 20258-K and other filingsDirector or officer change
24 Nov 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Oct 2025Lobbying filinglobbying engagement terminated (NORTHERN COMPASS GROUP LLC)
18 Jul 2025Lobbying filingnew lobbying registration (NORTHERN COMPASS GROUP LLC)
5 Jun 20258-K and other filingsDirector or officer change
5 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
24 Jan 20258-K and other filingsDirector or officer change
24 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Nov 2024Sharp changeMany funds opening a new position: many funds opening a new position, 111 vs usual 52 (2024-09-30); 3.3x the same period a year earlier
20 Aug 2024Sharp changeMany funds opening a new position: many funds opening a new position, 98 vs usual 48.50 (2024-06-30); 1.1x the same period a year earlier
13 Apr 2024Lobbying filinglobbying engagement terminated (CHAMBER HILL STRATEGIES)
1 Feb 20248-K and other filingsCompleted an acquisition or asset sale
13 Dec 20238-K and other filingsDirector or officer change
13 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 88 vs usual 50 (2023-06-30); 1.8x the same period a year earlier
10 Aug 20238-K and other filingsDirector or officer change
23 Jun 20238-K and other filingsDirector or officer change
30 May 20238-K and other filingsDirector or officer change
30 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Apr 2023Sharp changeLobbying on a new issue: lobbying on a new issue: TRD (2023-03-31)
19 Jan 20238-K and other filingsDirector or officer change
19 Jan 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Oct 20228-K and other filingsDirector or officer change
3 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Feb 20228-K and other filingsDirector or officer change
25 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Feb 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 304.0M vs usual 121.5M (2021-12-31); 1.8x the same period a year earlier
Insider net buying (open market)
Month from 1 Nov 2021: -$4.1M published
Month from 1 Dec 2021: -$7.3M published
Month from 1 Mar 2022: -$23.9M published
Month from 1 Jul 2022: -$468K published
Month from 1 Aug 2022: -$2.4M published
Month from 1 Oct 2022: $474K published
Month from 1 Dec 2022: -$431K published
Month from 1 Mar 2023: -$573K published
Month from 1 May 2023: -$1.5M published
Month from 1 Jun 2023: -$2.9M published
Month from 1 Nov 2023: -$400K published
Month from 1 Feb 2024: -$900K published
Month from 1 Mar 2024: -$4.8M published
Month from 1 May 2024: -$1.5M published
Month from 1 Jun 2024: -$4.8M published
Month from 1 Aug 2024: -$20.0M published
Month from 1 Sep 2024: -$1.9M published
Month from 1 Nov 2024: -$624K published
Month from 1 Mar 2025: -$1.5M published
Month from 1 May 2025: -$7.4M published
Month from 1 Jun 2025: -$1.5M published
Month from 1 Aug 2025: -$2.1M published
Month from 1 Sep 2025: -$15.0M published
Month from 1 Nov 2025: -$8.8M published
Month from 1 Dec 2025: -$430K published
Month from 1 Mar 2026: -$10.9M published
Month from 1 May 2026: -$1.5M published
Month from 1 Jul 2026: -$4.8M published
Month from 1 Aug 2026: -$32.7M published
Month from 1 Sep 2026: -$12.5M published
Month from 1 Nov 2026: -$293K published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 18 published
Revenue per quarter
Quarter ended 31 Dec 2021: $5.0B, -6.8% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $4.8B, -1.3% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $4.7B, -4.8% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $4.9B, -0.9% on a year earlier; public on 29 Oct 2022
Quarter ended 31 Dec 2022: $5.0B, +0.7% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $5.0B, +5.7% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $5.1B, +7.6% on a year earlier; public on 1 Aug 2023
Quarter ended 30 Sep 2023: $5.1B, +4.4% on a year earlier; public on 31 Oct 2023
Quarter ended 31 Dec 2023: $5.4B, +7.0% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $5.4B, +6.8% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $5.1B, +0.4% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $5.1B, +1.1% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $5.1B, -5.7% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $5.2B, -2.7% on a year earlier; public on 30 Apr 2025
Quarter ended 30 Jun 2025: $5.3B, +3.2% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $5.3B, +3.2% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $5.5B, +8.9% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $5.4B, +2.8% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $5.6B, +6.8% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $5.6B, +6.5% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $304.0M, +83% on a year earlier; public on 19 Feb 2022
Quarter ended 31 Mar 2022: $155.0M, +28% on a year earlier; public on 30 Apr 2022
Quarter ended 30 Jun 2022: $152.0M, +25% on a year earlier; public on 30 Jul 2022
Quarter ended 30 Sep 2022: $165.0M, +49% on a year earlier; public on 29 Oct 2022
Quarter ended 31 Dec 2022: $290.0M, -4.6% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $235.0M, +52% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $132.0M, -13% on a year earlier; public on 1 Aug 2023
Quarter ended 30 Sep 2023: $176.0M, +6.7% on a year earlier; public on 31 Oct 2023
Quarter ended 31 Dec 2023: $208.0M, -28% on a year earlier; public on 17 Feb 2024
Quarter ended 31 Mar 2024: $240.0M, +2.1% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $145.0M, +9.8% on a year earlier; public on 31 Jul 2024
Quarter ended 30 Sep 2024: $216.0M, +23% on a year earlier; public on 30 Oct 2024
Quarter ended 31 Dec 2024: $330.0M, +59% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $173.0M, -28% on a year earlier; public on 30 Apr 2025
Quarter ended 30 Jun 2025: $193.0M, +33% on a year earlier; public on 31 Jul 2025
Quarter ended 30 Sep 2025: $280.0M, +30% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $364.0M, +10% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $180.0M, +4.0% on a year earlier; public on 1 May 2026
Quarter ended 30 Jun 2026: $168.0M, -13% on a year earlier; public on 30 Jul 2026
Quarter ended 30 Sep 2026: $198.0M, -29% on a year earlier; public on 30 Oct 2026
Institutional holders (13F filers)
31 Dec 2021 report: 344; public on 14 Feb 2022
31 Mar 2022 report: 388; public on 16 May 2022
30 Jun 2022 report: 355; public on 15 Aug 2022
30 Sep 2022 report: 338; public on 14 Nov 2022
31 Dec 2022 report: 327; public on 14 Feb 2023
31 Mar 2023 report: 342; public on 15 May 2023
30 Jun 2023 report: 394; public on 14 Aug 2023
30 Sep 2023 report: 374; public on 14 Nov 2023
31 Dec 2023 report: 395; public on 14 Feb 2024
31 Mar 2024 report: 428; public on 15 May 2024
30 Jun 2024 report: 501; public on 14 Aug 2024
30 Sep 2024 report: 569; public on 14 Nov 2024
31 Dec 2024 report: 555; public on 14 Feb 2025
31 Mar 2025 report: 536; public on 15 May 2025
30 Jun 2025 report: 598; public on 14 Aug 2025
30 Sep 2025 report: 643; public on 14 Nov 2025
31 Dec 2025 report: 671; public on 17 Feb 2026
31 Mar 2026 report: 675; public on 15 May 2026
30 Jun 2026 report: 667; public on 14 Aug 2026
30 Sep 2026 report: 776; public on 16 Nov 2026
Federal obligations
Month from 1 Jan 2022: $1.5M published
Month from 1 Feb 2022: $2.2M published
Month from 1 Apr 2022: $0 published
Month from 1 May 2022: $761K published
Month from 1 Jun 2022: $320K published
Month from 1 Jul 2022: $3.2M published
Month from 1 Aug 2022: $13K published
Month from 1 Sep 2022: $6.1M published
Month from 1 Oct 2022: $446K published
Month from 1 Nov 2022: -$78K published
Month from 1 Mar 2023: $50K published
Month from 1 Apr 2023: $30K published
Month from 1 May 2023: $48K published
Month from 1 Jun 2023: $412K published
Month from 1 Aug 2023: $246K published
Month from 1 Sep 2023: -$232K published
Month from 1 Oct 2023: -$90K published
Month from 1 Nov 2023: $0 published
Month from 1 Jan 2024: $36K published
Month from 1 Mar 2024: $30K published
Month from 1 Jul 2024: $270K published
Month from 1 Oct 2024: -$27K published
Month from 1 Jan 2025: $36K published
Month from 1 Feb 2025: -$9K published
Month from 1 Apr 2025: $0 published
Month from 1 Jul 2025: $30K published
Month from 1 Oct 2025: $90K published
Month from 1 Nov 2025: -$12K published
Month from 1 Feb 2026: $135K published
Month from 1 Jun 2026: $135K published
Month from 1 Jul 2026: $350K published
Month from 1 Aug 2026: $350K published
Month from 1 Oct 2026: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $580K published
Quarter from 1 Apr 2022: $580K published
Quarter from 1 Jul 2022: $580K published
Quarter from 1 Oct 2022: $580K published
Quarter from 1 Jan 2023: $590K published
Quarter from 1 Apr 2023: $590K published
Quarter from 1 Jul 2023: $590K published
Quarter from 1 Oct 2023: $590K published
Quarter from 1 Jan 2024: $590K published
Quarter from 1 Apr 2024: $550K published
Quarter from 1 Jul 2024: $550K published
Quarter from 1 Oct 2024: $550K published
Quarter from 1 Jan 2025: $550K published
Quarter from 1 Apr 2025: $610K published
Quarter from 1 Jul 2025: $1.2M published
Quarter from 1 Oct 2025: $1.2M published
Quarter from 1 Jan 2026: $1.2M published
Quarter from 1 Apr 2026: $1.2M published
Quarter from 1 Jul 2026: $1.2M published
Quarter from 1 Oct 2026: $1.3M published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is H-1B/E-3 applications certified at 4 (Aug 2026), 56% below its normal month of 9.
  • Insider net buying (open market): Insiders sold a net $63.2M in the last 12 months (the 12 months before: -$36.3M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 18 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $5.6B in the latest quarter, +6.5% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 7 sales, $40.8M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Nov 2026Roy BluntDirectorSell1,000$293.00$293KForm 4
16 Sep 2026J Robert KerreyDirectorSell12,010$263.72$3.2MForm 4
14 Sep 2026Richard J MarkDirectorSell10,000$263.42$2.6MForm 4
3 Sep 2026Nadja WestDirectorSell1,152$258.80$298KForm 4
1 Sep 2026Lisa Y FooEVP, Chief Operating OfficerSell24,000$266.32$6.4MForm 4
26 Aug 2026Cecil D HaneyDirectorSell1,300$278.03$361KForm 4
26 Aug 2026Saumya SutariaCEOSell100,000$276.36$27.6MForm 4
10 Aug 2026Tammy RomoDirectorSell7,422$263.03$2.0MForm 4

776 institutions reported shares at the end of Q3 2026, 92% of the shares outstanding; 152 opened a position, 51 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.8.4M10.5%$2.1B-382K-4.4%
T. Rowe Price Associates Inc6.7M8.40%-1.3M-16%
Boston Partners4.1M5.11%$1.0B-369K-8.3%
Vanguard Portfolio Management LLC4.0M5.03%$1.0B-235K-5.6%
FMR LLC (Fidelity)3.9M4.93%$1.0B-70K-1.8%
Vanguard Capital Management LLC3.6M4.55%$925.6M-272K-7.0%
State Street Corp2.7M3.33%$677.4M-101K-3.7%
Glenview Capital Management, LLC2.0M2.57%$523.3M-188K-8.4%
Citadel Advisors LLC1.7M2.20%$447.0M-17K-0.9%
Arrowstreet Capital, Limited Partnership1.7M2.08%$423.0M-53K-3.1%

Federal contracts

All 14 federal contracts

No new award in 12 months; the latest was signed 1 May 2020. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
1 May 2020Department of Health and Human ServicesHealth Resources and Services Administration$3.3MDELTA STATE RURAL DEVELOPMENT NETWORK GRANT PROGRAM (DELTA)GrantUSAspending
28 Nov 2017Department of Health and Human ServicesHealth Resources and Services Administration$1.6MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending
28 Nov 2017Department of Health and Human ServicesHealth Resources and Services Administration$13.0MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending
16 Nov 2016Department of Health and Human ServicesHealth Resources and Services Administration$12.5MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending
16 Nov 2016Department of Health and Human ServicesHealth Resources and Services Administration$9.5MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending
24 Nov 2015Department of Health and Human ServicesHealth Resources and Services Administration$12.1MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending
3 Dec 2014Department of Health and Human ServicesHealth Resources and Services Administration$8.9MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending
3 Dec 2014Department of Health and Human ServicesHealth Resources and Services Administration$11.0MCHILDREN'S HOSPITALS GRADUATE MEDICAL EDUCATION PAYMENT PROGRAMGrantUSAspending

Company events

All 78 company events

In 12 months: 3 director or officer changes, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
22 Sep 2026Signed a major agreementSame filing: took on new debt8-K
10 Apr 2026Director or officer change8-K
30 Mar 2026Director or officer change8-K
24 Nov 2025Director or officer change8-K
18 Nov 2025Signed a major agreementSame filing: took on new debt8-K
5 Nov 2025Signed a major agreementSame filing: took on new debt8-K
5 Jun 2025Director or officer change8-K
24 Jan 2025Director or officer change8-K

2,591 open postings; careers site tracked since 21 Nov 2026. Most in People & recruiting 2%, Operations & administration 2%, Research & science 1%, Nuclear fission & fusion 1%.

PostedJobLocation
14 Nov 2026Registered Nurse (RN) - ERSan Ramon, CA, United States
13 Nov 2026Physical Therapist for BHS Physicians NetworkEl Paso, TX, United States
13 Nov 2026Registered NurseWorcester, MA, United States
13 Nov 2026Registered Nurse (RN) - LDRPFort Mill, SC, United States
13 Nov 2026Registered Nurse (RN) - Operating RoomFramingham, MA, United States
13 Nov 2026Registered Nurse (RN) - ObstetricsWorcester, MA, United States
13 Nov 2026Medical Lab Scientist (MLS)Research & scienceAZ, United States
13 Nov 2026Medical Lab Tech II (MLT)AZ, United States

Reported lobbying spend: $1.3M in Q3 2026, $1.2M in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jul 2025EndedNorthern Compass Group LLCfor Brownstein Hyatt Farber Schreck LLP Obo Tenet Business Services CorporationNot statedFiling
20 Jun 2025NewNorthern Compass Group LLCfor Brownstein Hyatt Farber Schreck LLP Obo Tenet Business Services CorporationIssues related to healthcare policy. Medicaid coverage issues.Health issuesFiling
1 Jan 2024EndedChamber Hill Strategiesfor Tenet Healthcare CorporationNot statedFiling
6 Apr 2020NewCarmen Group Incorporatedfor Tenet HealthcareCOVID-19 related issuesHealth issuesFiling
20 Mar 2020NewBrownstein Hyatt Farber Schreck, LLPfor Tenet Business Services CorporationHealth issuesFiling
30 Apr 2018EndedLincoln Policy Groupfor United Surgical Partners InternationalHealth care regulatory and legislative issuesMedicare/MedicaidFiling
26 Jan 2018EndedHealth Policy Source, Inc.for Conifer Health SolutionsMedicare and Medicaid medical debt-related issues, as well as associated transactional concerns involving payment, data, and quality metricsMedicare/MedicaidFiling
1 Jan 2018EndedJames P. Keesefor Southwest Orthopedic And Spine Hospital, LLCNot statedFiling

Layoff notices

All 2 layoff notices

No notice in 12 months; the latest is dated 20 Jul 2020. State WARN notices.

NoticeSiteWorkersJobs endSource
20 Jul 2020Conifer Revenue Cycle SolutionsCook County, IL341 Sep 2020layoffNotice
8 Sep 2017Conifer Revenue Cycle Solutions, LLCCook County, IL341 Nov 2017layoffNotice

The 5 newest of 289 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

18 May 2021confirmed

Confirmed across sources Institutional holdings and Lobbying

Tenet Healthcare Corporation New (THC): reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year, while it saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Lobbying: Lobbying spend jump, became public on 20 Apr 2021
  • Institutional holdings: Many funds opening a new position, became public on 17 May 2021
2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K2020-09-30: $670K2020-12-31: $730K2021-03-31: $780K
The quarter ended 31 Mar 2021 against the 8 quarters before it. this quarterearliernormal: $365K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 20 Apr 2021

Tenet Healthcare Corporation New reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year.

This period
$780K (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
$365K
Typical spread (median absolute deviation)
$25K
How far from its usual level
+11.2
Same quarter last year
$380K
History used
3,835 days
2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K2020-09-30: $670K2020-12-31: $730K2021-03-31: $780K
the quarter ended 31 Mar 20218 earlier quartersnormal: $365K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Institutional holdings: Many funds opening a new position became public on 17 May 2021

Tenet Healthcare Corporation New saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year.

This period
60 (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
36
Typical spread (median absolute deviation)
4
How far from its usual level
+4.0
Same quarter last year
45
History used
2,739 days
2019-03-31: 362019-06-30: 362019-09-30: 322019-12-31: 522020-03-31: 452020-06-30: 332020-09-30: 322020-12-31: 512021-03-31: 60
the quarter ended 31 Mar 20218 earlier quartersnormal: 36

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

16 Feb 2021confirmed

Confirmed across sources Institutional holdings and Lobbying

Tenet Healthcare Corporation New (THC): reported $580K of lobbying spend for the quarter ended 31 Dec 2020, 1.7× the same quarter last year, while it saw 51 13F filers open a new position in the quarter ended 31 Dec 2020, 1.9% below the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Lobbying: Lobbying spend jump, became public on 19 Jan 2021
  • Institutional holdings: Many funds opening a new position, became public on 16 Feb 2021
2018-12-31: $360K2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K2020-09-30: $670K2020-12-31: $580K
The quarter ended 31 Dec 2020 against the 8 quarters before it. this quarterearliernormal: $355K
See the evidence (2 changes)

Lobbying: Lobbying spend jump became public on 19 Jan 2021

Tenet Healthcare Corporation New reported $580K of lobbying spend for the quarter ended 31 Dec 2020, 1.7× the same quarter last year.

This period
$580K (the quarter ended 31 Dec 2020)
Normal quarter (median of 8 earlier)
$355K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+6.3
Same quarter last year
$340K
History used
3,653 days
2018-12-31: $360K2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K2020-09-30: $670K2020-12-31: $580K
the quarter ended 31 Dec 20208 earlier quartersnormal: $355K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Institutional holdings: Many funds opening a new position became public on 16 Feb 2021

Tenet Healthcare Corporation New saw 51 13F filers open a new position in the quarter ended 31 Dec 2020, 1.9% below the same quarter last year.

This period
51 (the quarter ended 31 Dec 2020)
Normal quarter (median of 8 earlier)
34.5
Typical spread (median absolute deviation)
2.5
How far from its usual level
+4.5
Same quarter last year
52
History used
2,649 days
2018-12-31: 312019-03-31: 362019-06-30: 362019-09-30: 322019-12-31: 522020-03-31: 452020-06-30: 332020-09-30: 322020-12-31: 51
the quarter ended 31 Dec 20208 earlier quartersnormal: 34.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

21 Jul 2020confirmed

Confirmed across sources Layoff notices and Lobbying

Tenet Healthcare Corporation New (THC): filed a WARN layoff notice covering 34 workers within 30 days, while it reported $690K of lobbying spend for the quarter ended 30 Jun 2020, 2.0× the same quarter last year. Two unrelated kinds of activity on the same day.

  • Layoff notices: WARN layoff notice, became public on 21 Jul 2020
  • Lobbying: Lobbying spend jump, became public on 20 Jul 2020
2018-06-30: $390K2018-09-30: $370K2018-12-31: $360K2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K
The quarter ended 30 Jun 2020 against the 8 quarters before it. this quarterearliernormal: $355K
See the evidence (2 changes)

Layoff notices: WARN layoff notice became public on 21 Jul 2020

Tenet Healthcare Corporation New filed a WARN layoff notice covering 34 workers within 30 days.

Notices in the window
1
Workers named
34
Window
21 Jun 2020 to 21 Jul 2020

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Lobbying: Lobbying spend jump became public on 20 Jul 2020

Tenet Healthcare Corporation New reported $690K of lobbying spend for the quarter ended 30 Jun 2020, 2.0× the same quarter last year.

This period
$690K (the quarter ended 30 Jun 2020)
Normal quarter (median of 8 earlier)
$355K
Typical spread (median absolute deviation)
$15K
How far from its usual level
+9.4
Same quarter last year
$350K
History used
3,379 days
2018-06-30: $390K2018-09-30: $370K2018-12-31: $360K2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K
the quarter ended 30 Jun 20208 earlier quartersnormal: $355K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 10 Apr 2026Filings record

    Director or officer change

  2. 30 Mar 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  3. 30 Mar 2026Filings record

    Director or officer change

  4. 17 Feb 2026Institutional holdings record

    LONE PINE CAPITAL LLC opened a $355.0M position (2025Q4 13F)

  5. 20 Jan 2026Lobbying change

    reported $1.2M of lobbying spend for the quarter ended 31 Dec 2025, 2.1× the same quarter last year.

    Same quarter last year: $550K; its normal quarter is $570K.

    See the evidence
    This period
    $1.2M (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    $570K
    Typical spread (median absolute deviation)
    $20K
    How far from its usual level
    +10.5
    Same quarter last year
    $550K
    History used
    6,301 days
    2023-12-31: $590K2024-03-31: $550K2024-06-30: $550K2024-09-30: $550K2024-12-31: $550K2025-03-31: $610K2025-06-30: $1.2M2025-09-30: $1.2M2025-12-31: $1.2M
    the quarter ended 31 Dec 20258 earlier quartersnormal: $570K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  6. 24 Nov 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 24 Nov 2025Filings record

    Director or officer change

  8. 17 Oct 2025Lobbying record

    BROWNSTEIN HYATT FARBER SCHRECK LLP OBO TENET BUSINESS SERVICES CORPORATION: lobbying engagement terminated (NORTHERN COMPASS GROUP LLC) (dated 1 Jul 2025)

  9. 18 Jul 2025Lobbying record

    BROWNSTEIN HYATT FARBER SCHRECK LLP OBO TENET BUSINESS SERVICES CORPORATION: new lobbying registration (NORTHERN COMPASS GROUP LLC) (dated 20 Jun 2025)

  10. 5 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 5 Jun 2025Filings record

    Director or officer change

  12. 24 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 24 Jan 2025Filings record

    Director or officer change

  14. 14 Nov 2024Institutional holdings change

    saw 111 13F filers open a new position in the quarter ended 30 Sep 2024, 3.3× the same quarter last year.

    Same quarter last year: 34; its normal quarter is 52.

    See the evidence
    This period
    111 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    52
    Typical spread (median absolute deviation)
    10.5
    How far from its usual level
    +3.8
    Same quarter last year
    34
    History used
    4,018 days
    2022-09-30: 452022-12-31: 562023-03-31: 462023-06-30: 882023-09-30: 342023-12-31: 482024-03-31: 662024-06-30: 982024-09-30: 111
    the quarter ended 30 Sep 20248 earlier quartersnormal: 52

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  15. 14 Aug 2024Institutional holdings change

    saw 98 13F filers open a new position in the quarter ended 30 Jun 2024, 1.1× the same quarter last year.

    Same quarter last year: 88; its normal quarter is 48.5.

    See the evidence
    This period
    98 (the quarter ended 30 Jun 2024)
    Normal quarter (median of 8 earlier)
    48.5
    Typical spread (median absolute deviation)
    5.5
    How far from its usual level
    +6.1
    Same quarter last year
    88
    History used
    3,926 days
    2022-06-30: 492022-09-30: 452022-12-31: 562023-03-31: 462023-06-30: 882023-09-30: 342023-12-31: 482024-03-31: 662024-06-30: 98
    the quarter ended 30 Jun 20248 earlier quartersnormal: 48.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  16. 13 Apr 2024Lobbying record

    TENET HEALTHCARE CORPORATION: lobbying engagement terminated (CHAMBER HILL STRATEGIES) (dated 1 Jan 2024)

  17. 1 Feb 2024Filings record

    Completed an acquisition or asset sale

  18. 13 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 13 Dec 2023Filings record

    Director or officer change

  20. 14 Aug 2023Institutional holdings change

    saw 88 13F filers open a new position in the quarter ended 30 Jun 2023, 1.8× the same quarter last year.

    Same quarter last year: 49; its normal quarter is 50.

    See the evidence
    This period
    88 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    50
    Typical spread (median absolute deviation)
    4.5
    How far from its usual level
    +5.7
    Same quarter last year
    49
    History used
    3,560 days
    2021-06-30: 512021-09-30: 402021-12-31: 512022-03-31: 692022-06-30: 492022-09-30: 452022-12-31: 562023-03-31: 462023-06-30: 88
    the quarter ended 30 Jun 20238 earlier quartersnormal: 50

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  21. 10 Aug 2023Filings record

    Director or officer change

  22. 23 Jun 2023Filings record

    Director or officer change

  23. 30 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 30 May 2023Filings record

    Director or officer change

  25. 20 Apr 2023Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['TRD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12624519
  26. 19 Jan 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 19 Jan 2023Filings record

    Director or officer change

  28. 28 Oct 2022Insiders record

    Cancelmi Daniel J (EVP & Chief Financial Officer) bought 11,000 shares of THC ($473,770) (dated 27 Oct 2022)

  29. 3 Oct 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 3 Oct 2022Filings record

    Director or officer change

  31. 25 Feb 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  32. 25 Feb 2022Filings record

    Director or officer change

  33. 22 Feb 2022Financials change

    spent $304.0M on capital projects in the quarter ended 31 Dec 2021, 1.8× the same quarter last year.

    Same quarter last year: $166.0M; its normal quarter is $121.5M.

    See the evidence
    This period
    $304.0M (the quarter ended 31 Dec 2021)
    Normal quarter (median of 8 earlier)
    $121.5M
    Typical spread (median absolute deviation)
    $25.5M
    How far from its usual level
    +4.8
    Same quarter last year
    $166.0M
    History used
    3,287 days
    2019-12-31: $178.0M2020-03-31: $182.0M2020-06-30: $106.0M2020-09-30: $86.0M2020-12-31: $166.0M2021-03-31: $121.0M2021-06-30: $122.0M2021-09-30: $111.0M2021-12-31: $304.0M
    the quarter ended 31 Dec 20218 earlier quartersnormal: $121.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  34. 3 Sep 2021Filings record

    Director or officer change

  35. 29 Aug 2021Government contracts change

    booked $6.3M in federal contract and grant obligations in July 2021, 33× the same month last year.

    Same month last year: $194K; its normal month is $532K.

    See the evidence
    This period
    $6.3M (July 2021)
    Normal month (median of 5 earlier)
    $532K
    Typical spread (median absolute deviation)
    $338K
    How far from its usual level
    +5.8
    Same month last year
    $194K
    History used
    4,743 days
    2016-07-01: $532K2017-07-01: $10.5M2018-07-01: $580K2019-07-01: $02020-07-01: $194K2021-07-01: $6.3M
    July 20215 earlier monthsnormal: $532K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  36. 10 Aug 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  37. 10 Aug 2021Filings record

    Director or officer change

  38. 18 May 2021several at once

    reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year, while it saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year. Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Lobbying: Lobbying spend jump became public on 20 Apr 2021

    Tenet Healthcare Corporation New reported $780K of lobbying spend for the quarter ended 31 Mar 2021, 2.1× the same quarter last year.

    This period
    $780K (the quarter ended 31 Mar 2021)
    Normal quarter (median of 8 earlier)
    $365K
    Typical spread (median absolute deviation)
    $25K
    How far from its usual level
    +11.2
    Same quarter last year
    $380K
    History used
    3,835 days
    2019-03-31: $350K2019-06-30: $350K2019-09-30: $340K2019-12-31: $340K2020-03-31: $380K2020-06-30: $690K2020-09-30: $670K2020-12-31: $730K2021-03-31: $780K
    the quarter ended 31 Mar 20218 earlier quartersnormal: $365K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

    Institutional holdings: Many funds opening a new position became public on 17 May 2021

    Tenet Healthcare Corporation New saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year.

    This period
    60 (the quarter ended 31 Mar 2021)
    Normal quarter (median of 8 earlier)
    36
    Typical spread (median absolute deviation)
    4
    How far from its usual level
    +4.0
    Same quarter last year
    45
    History used
    2,739 days
    2019-03-31: 362019-06-30: 362019-09-30: 322019-12-31: 522020-03-31: 452020-06-30: 332020-09-30: 322020-12-31: 512021-03-31: 60
    the quarter ended 31 Mar 20218 earlier quartersnormal: 36

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  39. 17 May 2021Institutional holdings change

    saw 60 13F filers open a new position in the quarter ended 31 Mar 2021, 1.3× the same quarter last year.

    Same quarter last year: 45; its normal quarter is 36.

    See the evidence
    This period
    60 (the quarter ended 31 Mar 2021)
    Normal quarter (median of 8 earlier)
    36
    Typical spread (median absolute deviation)
    4
    How far from its usual level
    +4.0
    Same quarter last year
    45
    History used
    2,739 days
    2019-03-31: 362019-06-30: 362019-09-30: 322019-12-31: 522020-03-31: 452020-06-30: 332020-09-30: 322020-12-31: 512021-03-31: 60
    the quarter ended 31 Mar 20218 earlier quartersnormal: 36

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  40. 23 Apr 2021Filings record

    Director or officer change

Showing the newest 40 of 153 entries; narrow the window or the kind of data to see older ones.

Not listed: 256 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000070318
Ticker
THC
Domain
tenethealth.com
Employer name
BHS Physicians Network, Inc., Cardiology Physicians, LLC, Conifer Revenue Cycle Solutions, LLC, Desert Regional Medical Center and 7 more (11 unverified)
Fein
20-3059260, 27-3176652, 47-4291438, 51-0363108 and 7 more (11 unverified)
Hq location
TX|DALLAS|75254 (1 unverified)
Lobbying client
brownstein hyatt farber schreck llp obo tenet business services, conifer health solutions, conifer revenue cycle solutions llc a subsidiary of tenet healthcare, southwest orthopedic and spine hospital and 4 more
Name
601 N 30th Street III, Inc, 601 N 30th Street I, L.L.C, Advanced Ambulatory Surgical Care, L.P, Advanced Center for Surgery – Vero Beach, LLC and 1198 more
Uei
CZSKJRUMEYW7, LMX8WWM3XPL5, W77RQ2SEJSZ3, WMCQYX3HHZJ7
Wikidata
Q3518066
Wikipedia
Tenet Healthcare
  • DOL H-1B labor condition applications and PERM certifications73 data points10 Nov 2025 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)40 records, 258 data points31 Dec 2002 to 30 Sep 2026
  • SEC Form 13F institutional holdings1 record, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)203 records12 Jan 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)974 data points31 Dec 2007 to 23 Oct 2026
  • SEC Form 4 insider transactions120 records, 408 data points10 Nov 2016 to 13 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards14 records, 520 data points5 Aug 2008 to 8 Jul 2026
  • WARN layoff notices (state labor agencies)2 records, 6 data points4 Sep 2017 to 20 Jul 2020
  • Wikipedia pageviews2881 data points1 Jan 2019 to 20 Nov 2026